Thoratec Presentation At J.P. Morgan Healthcare Conference To Be Webcast PR Newswire PLEASANTON, Calif., Jan. 3, 2013 PLEASANTON, Calif., Jan. 3, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the 31^st Annual J.P. Morgan Healthcare Conference on Monday, January 7. Gary F. Burbach, President and Chief Executive Officer, will provide an update on the company, beginning at 8:00 a.m., Pacific Standard Time (11:00 a.m., Eastern Standard Time). The presentation and ensuing breakout session will be available through the conference website at http://jpmorgan.metameetings.com/webcasts/healthcare13/directlink?ticker=THOR, or on the company's website at http://www.thoratec.com. Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com. Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH. SOURCE Thoratec Corporation Website: http://www.thoratec.com Contact: Taylor Harris, Vice President and Chief Financial Officer, Thoratec Corporation, +1-925-738-0047
Thoratec Presentation At J.P. Morgan Healthcare Conference To Be Webcast
Press spacebar to pause and continue. Press esc to stop.